{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:56:06Z","timestamp":1785527766785,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Augsburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The recently introduced H&amp;E-based biomarker SARIFA (Stroma AReactive Invasion Front Areas) is defined by a direct tumor-adipocyte interaction at the invasion front and is highly predictive for worse outcome in colorectal cancer (CRC). Further analysis revealed an altered lipid metabolism and an immune dysregulation in SARIFA-positive cancers, specifically reduced natural killer (NK) cells. In this study, we investigated whether these lower NK cells in SARIFA-positive patients persist after tumor resection, indicating a patient-intrinsic factor that might contribute to the development of SARIFA-positive tumors. Flow cytometric analysis of NK cells of CRC patients was performed before, 7\u201310 days and 6 months after resection of the tumors. Using multiplex ELISA (enzyme-linked immunosorbent assay), various inflammatory mediators were examined. 28 SARIFA-negative, 12 SARIFA-positive patients and 27 matched healthy individuals were included. Preoperative NK cell values were previously published and showed significantly lower values for SARIFA-positive patients. Postoperatively NK cells and all their subsets declined in SARIFA-negative patients. Regarding the 6 months follow-up measurements, SARIFA-negative patients showed increasing values of NK cells reaching the initial level, while lower NK-cell levels persisted in SARIFA-positive patients. Multiplex ELISA of inflammatory mediators revealed a postoperative increase of IL5, IL6 and IL8 but no differences between SARIFA-positive and -negative patients. Postoperative measurements of NK cells and different subsets showed a persisting difference between SARIFA-positive and SARIFA-negative patients six months after surgery, which may indicate that patient-intrinsic immunological characteristics are associated with the development of the more aggressive SARIFA-positive tumors.<\/jats:p>","DOI":"10.1038\/s41598-026-63238-z","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:48:11Z","timestamp":1785286091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinct NK cell dynamics in SARIFA positive colorectal cancer patients indicate persistent patient-intrinsic immune signatures after tumor resection"],"prefix":"10.1038","volume":"16","author":[{"given":"Florian","family":"Sommer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Anthuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Grosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"L\u00f6hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Allmendinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Siebenh\u00fcter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nic G.","family":"Reitsam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"M\u00e4rkl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2776-1590","authenticated-orcid":false,"given":"Johanna","family":"Waidhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"9","key":"63238_CR1","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/s41379-022-01086-8","volume":"35","author":"CH Bergsland","year":"2022","unstructured":"Bergsland, C. H. et al. Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancer. Mod. Pathol. 35 (9), 1236\u20131246. https:\/\/doi.org\/10.1038\/s41379-022-01086-8 (2022).","journal-title":"Mod. Pathol."},{"issue":"1","key":"63238_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3395-1","volume":"17","author":"M Shibutani","year":"2017","unstructured":"Shibutani, M. et al. The peripheral monocyte count is associated with the density of tumor-associated macrophages in the tumor microenvironment of colorectal cancer: A retrospective study. BMC Cancer 17(1), 404. https:\/\/doi.org\/10.1186\/s12885-017-3395-1 (2017).","journal-title":"BMC Cancer"},{"issue":"4","key":"63238_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/cjp2.267","volume":"8","author":"T Cavalleri","year":"2022","unstructured":"Cavalleri, T. et al. Tumor-associated macrophages and risk of recurrence in stage III colorectal cancer. J. Pathol. Clin. Res. 8 (4), 307\u2013312. https:\/\/doi.org\/10.1002\/cjp2.267 (2022).","journal-title":"J. Pathol. Clin. Res."},{"issue":"8","key":"63238_CR4","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00262-021-03127-8","volume":"71","author":"J Waidhauser","year":"2022","unstructured":"Waidhauser, J. et al. Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma. Cancer Immunol. Immunother. 71(8), 1937\u201347. https:\/\/doi.org\/10.1007\/s00262-021-03127-8 (2022).","journal-title":"Cancer Immunol. Immunother."},{"issue":"9","key":"63238_CR5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41416-025-02972-z","volume":"132","author":"VV Tapiainen","year":"2025","unstructured":"Tapiainen, V. V. et al. Stroma AReactive Invasion Front Areas (SARIFA), tumour immune microenvironment, and survival in colorectal cancer. Br. J. Cancer 132(9), 805\u201313. https:\/\/doi.org\/10.1038\/s41416-025-02972-z (2025).","journal-title":"Br. J. Cancer"},{"key":"63238_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194880","author":"B Martin","year":"2021","unstructured":"Martin, B. et al. Stroma AReactive Invasion Front Areas (SARIFA)-a new easily to determine biomarker in colon cancer-results of a retrospective study. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers13194880 (2021).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"63238_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/path.5810","volume":"256","author":"B Grosser","year":"2022","unstructured":"Grosser, B. et al. Stroma AReactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor-promoting adipocytes. J. Pathol. 256(1), 71\u201382. https:\/\/doi.org\/10.1002\/path.5810 (2022).","journal-title":"J. Pathol."},{"issue":"1","key":"63238_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12519-9","volume":"24","author":"P Grochowski","year":"2024","unstructured":"Grochowski, P. et al. The concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma. BMC Cancer 24(1), 768. https:\/\/doi.org\/10.1186\/s12885-024-12519-9 (2024).","journal-title":"BMC Cancer"},{"key":"63238_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101913","volume":"44","author":"NG Reitsam","year":"2024","unstructured":"Reitsam, N. G. et al. Stroma AReactive Invasion Front Areas (SARIFA): A novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportion. Transl. Oncol. 44, 101913. https:\/\/doi.org\/10.1016\/j.tranon.2024.101913 (2024).","journal-title":"Transl. Oncol."},{"issue":"1","key":"63238_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-024-00349-z","volume":"12","author":"K Offermans","year":"2024","unstructured":"Offermans, K. et al. The relationship between Stroma AReactive Invasion Front Areas (SARIFA), Warburg-subtype and survival: Results from a large prospective series of colorectal cancer patients. Cancer Metab. 12(1), 21. https:\/\/doi.org\/10.1186\/s40170-024-00349-z (2024).","journal-title":"Cancer Metab."},{"issue":"9","key":"63238_CR11","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/PAS.0000000000002408","volume":"49","author":"NG Reitsam","year":"2025","unstructured":"Reitsam, N. G. et al. Prognostic and Predictive Value of SARIFA-status Within Molecular Subgroups of Colorectal Cancer: Insights From the Netherlands Cohort Study. Am. J. Surg. Pathol. 49 (9), 956\u2013969. https:\/\/doi.org\/10.1097\/PAS.0000000000002408 (2025).","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"63238_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/his.15501","volume":"87","author":"S Foersch","year":"2025","unstructured":"Foersch, S. et al. Stroma areactive invasion front areas (SARIFA) in 1,298 pT3\/pT4 colorectal cancers: A strong prognostic parameter complementing established morphological criteria. Histopathology 87(3), 464\u201373. https:\/\/doi.org\/10.1111\/his.15501 (2025).","journal-title":"Histopathology"},{"issue":"1","key":"63238_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00662-2","volume":"8","author":"B M\u00e4rkl","year":"2024","unstructured":"M\u00e4rkl, B., Reitsam, N. G., Grochowski, P., Waidhauser, J. & Grosser, B. The SARIFA biomarker in the context of basic research of lipid-driven cancers. NPJ Precis. Oncol. 8(1), 165. https:\/\/doi.org\/10.1038\/s41698-024-00662-2 (2024).","journal-title":"NPJ Precis. Oncol."},{"issue":"1","key":"63238_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s10120-023-01436-8","volume":"27","author":"B Grosser","year":"2024","unstructured":"Grosser, B. et al. Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor-adipocyte interaction indicating an altered immune response. Gastric Cancer. 27 (1), 72\u201385. https:\/\/doi.org\/10.1007\/s10120-023-01436-8 (2024).","journal-title":"Gastric Cancer"},{"key":"63238_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030994","author":"NG Reitsam","year":"2023","unstructured":"Reitsam, N. G. et al. Alterations in natural killer cells in colorectal cancer patients with Stroma AReactive Invasion Front Areas (SARIFA). Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers15030994 (2023).","journal-title":"Cancers (Basel)"},{"issue":"2","key":"63238_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","volume":"23","author":"NK Wolf","year":"2023","unstructured":"Wolf, N. K., Kissiov, D. U. & Raulet, D. H. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nat. Rev. Immunol. 23(2), 90\u2013105. https:\/\/doi.org\/10.1038\/s41577-022-00732-1 (2023).","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"63238_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100930","volume":"14","author":"S Nersesian","year":"2021","unstructured":"Nersesian, S. et al. NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis. Transl. Oncol. 14(1), 100930. https:\/\/doi.org\/10.1016\/j.tranon.2020.100930 (2021).","journal-title":"Transl. Oncol."},{"issue":"1","key":"63238_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00257-6","volume":"9","author":"Q Wu","year":"2021","unstructured":"Wu, Q. et al. Cancer-associated adipocytes as immunomodulators in cancer. Biomark. Res. 9(1), 2. https:\/\/doi.org\/10.1186\/s40364-020-00257-6 (2021).","journal-title":"Biomark. Res."},{"issue":"1","key":"63238_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13046-019-1310-0","volume":"38","author":"J Wu","year":"2019","unstructured":"Wu, J. et al. IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma. J. Experimental Clin. Cancer Res. 38 (1), 321. https:\/\/doi.org\/10.1186\/s13046-019-1310-0 (2019).","journal-title":"J. Experimental Clin. Cancer Res."},{"key":"63238_CR20","doi-asserted-by":"publisher","unstructured":"B\u00e4hr, I., Spielmann, J., Quandt, D. & Kielstein, H. Obesity-Associated Alterations of Natural Killer Cells and Immunosurveillance of Cancer. Front. Immunol. 11\u20132020. https:\/\/doi.org\/10.3389\/fimmu.2020.00245 (2020).","DOI":"10.3389\/fimmu.2020.00245"},{"key":"63238_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12061408","author":"J Waidhauser","year":"2022","unstructured":"Waidhauser, J. et al. Circulating lymphocytes reflect the local immune response in patients with colorectal carcinoma. Diagnostics https:\/\/doi.org\/10.3390\/diagnostics12061408 (2022).","journal-title":"Diagnostics"},{"key":"63238_CR22","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK. AWMF). S3-Leitlinie Kolorektales Karzinom, Langversion 2.0, 2017 (AWMF, )."},{"issue":"2","key":"63238_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo, D., Demartines, N. & Clavien, P. A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 240(2), 205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae (2004).","journal-title":"Ann. Surg."},{"key":"63238_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081787","author":"L Angka","year":"2017","unstructured":"Angka, L. et al. Dysfunctional natural killer cells in the aftermath of cancer surgery. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms18081787 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"63238_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.807539","volume":"13","author":"C Zhou","year":"2022","unstructured":"Zhou, C., Wang, Z., Jiang, B., Di, J. & Su, X. Monitoring pre- and post-operative immune alterations in patients with locoregional colorectal cancer who underwent laparoscopy by single-cell mass cytometry. Front. Immunol. 13, 807539. https:\/\/doi.org\/10.3389\/fimmu.2022.807539 (2022).","journal-title":"Front. Immunol."},{"key":"63238_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111378","author":"M Market","year":"2021","unstructured":"Market, M., Tennakoon, G. & Auer, R. C. Postoperative natural killer cell dysfunction: The prime suspect in the case of metastasis following curative cancer surgery. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms222111378 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"63238_CR27","doi-asserted-by":"crossref","unstructured":"Angka L, Martel AB, Kilgour M, Jeong A, Sadiq M, de Souza CT, et al. Natural Killer Cell IFNgamma Secretion is Profoundly Suppressed Following Colorectal Cancer Surgery. Ann Surg Oncol. 2018;25(12):3747-54, doi:10.1245\/s10434-018-6691-3.","DOI":"10.1245\/s10434-018-6691-3"},{"issue":"2","key":"63238_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12307-012-0125-8","volume":"6","author":"A Stojanovic","year":"2013","unstructured":"Stojanovic, A., Correia, M. P. & Cerwenka, A. Shaping of NK cell responses by the tumor microenvironment. Cancer Microenviron. 6(2), 135\u201346. https:\/\/doi.org\/10.1007\/s12307-012-0125-8 (2013).","journal-title":"Cancer Microenviron."},{"key":"63238_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00490","volume":"4","author":"J Baginska","year":"2013","unstructured":"Baginska, J. et al. The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity. Front. Immunol. 4, 490. https:\/\/doi.org\/10.3389\/fimmu.2013.00490 (2013).","journal-title":"Front. Immunol."},{"issue":"10","key":"63238_CR30","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","volume":"18","author":"R Spolski","year":"2018","unstructured":"Spolski, R., Li, P. & Leonard, W. J. Biology and regulation of IL-2: From molecular mechanisms to human therapy. Nat. Rev. Immunol. 18(10), 648\u201359. https:\/\/doi.org\/10.1038\/s41577-018-0046-y (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"63238_CR31","doi-asserted-by":"crossref","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234\u2009\u2013\u200948, doi:10.1038\/nrclinonc.2018.8.","DOI":"10.1038\/nrclinonc.2018.8"},{"issue":"4","key":"63238_CR32","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.immuni.2019.03.022","volume":"50","author":"M Dougan","year":"2019","unstructured":"Dougan, M., Dranoff, G. & Dougan, S. K. GM-CSF, IL-3, and IL-5 family of cytokines: Regulators of inflammation. Immunity 50(4), 796\u2013811. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.022 (2019).","journal-title":"Immunity"},{"key":"63238_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115267","volume":"218","author":"C Meier","year":"2025","unstructured":"Meier, C. & Brieger, A. The role of IL-8 in cancer development and its impact on immunotherapy resistance. Eur. J. Cancer 218, 115267. https:\/\/doi.org\/10.1016\/j.ejca.2025.115267 (2025).","journal-title":"Eur. J. Cancer"},{"key":"63238_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01869","volume":"9","author":"AM Abel","year":"2018","unstructured":"Abel, A. M., Yang, C., Thakar, M. S. & Malarkannan, S. Natural killer cells: Development, maturation, and clinical utilization. Front. Immunol. 9, 1869. https:\/\/doi.org\/10.3389\/fimmu.2018.01869 (2018).","journal-title":"Front. Immunol."},{"issue":"12","key":"63238_CR35","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1038\/s41416-023-02258-2","volume":"128","author":"M Kastinen","year":"2023","unstructured":"Kastinen, M. et al. Immunological and prognostic significance of tumour necrosis in colorectal cancer. Br. J. Cancer 128(12), 2218\u201326. https:\/\/doi.org\/10.1038\/s41416-023-02258-2 (2023).","journal-title":"Br. J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63238-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63238-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63238-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:14:39Z","timestamp":1785521679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63238-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["63238"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-63238-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Ludwig Maximilian University of Munich, the relevant ethics committee for our institution (Reference: Project No. 18-726) and was performed in accordance with the principles of the Declaration of Helsinki at University Hospital Augsburg, Germany.","order":2,"name":"Ethics","label":"<b>Institutional review board statement<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients prior to their inclusion in the study.","order":3,"name":"Ethics","label":"<b>Informed consent statement<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23536"}}